These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7193368)

  • 41. [Prostate cancer--ablative hormone therapy or orchiectomy?].
    Schmeller N
    Fortschr Med; 1988 Apr; 106(12):239. PubMed ID: 3397028
    [No Abstract]   [Full Text] [Related]  

  • 42. [Cardiovascular complications of oestrogen treatment in prostatic carcinoma (author's transl)].
    Héritier P; Hessler D
    Ther Umsch; 1978 Oct; 35(10):841-4. PubMed ID: 705679
    [No Abstract]   [Full Text] [Related]  

  • 43. Flare reaction during the initial treatment period with medroxyprogesterone acetate in patients with hormone-resistant prostatic cancer.
    Fosså SD; Urnes T
    Eur Urol; 1986; 12(4):257-9. PubMed ID: 3743595
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Studies on an application of synthetic ACTH (giractide acetate) as a therapeutic agents: the first report of a special reference on therapy of hepatic disease (author's transl)].
    Sugi S; Hara H; Takeda H; Oma H
    Igaku Kenkyu; 1978 Aug; 48(6):488-92. PubMed ID: 219656
    [No Abstract]   [Full Text] [Related]  

  • 45. [Hormones and cancer].
    Med Klin; 1967 May; 62(20):789-91. PubMed ID: 4297507
    [No Abstract]   [Full Text] [Related]  

  • 46. EORTC Genitourinary Group Monograph 2, Part A: Therapeutic principles in metastatic prostatic cancer. Proceedings of a symposium held in Rotterdam, The Netherlands, September 14 and 15, 1984.
    Prog Clin Biol Res; 1985; 185A():1-466. PubMed ID: 4041041
    [No Abstract]   [Full Text] [Related]  

  • 47. [Hormone therapy of prostatic carcinoma].
    Klosterhalfen H
    Dtsch Med Wochenschr; 1977 Jun; 102(25):947. PubMed ID: 872769
    [No Abstract]   [Full Text] [Related]  

  • 48. [Thrombocytopenia following hormone treatment for prostatic carcinoma (author's transl)].
    Mende S; Pribilla W
    Dtsch Med Wochenschr; 1974 May; 99(21):1137-40. PubMed ID: 4843439
    [No Abstract]   [Full Text] [Related]  

  • 49. Effects of antiandrogens on prolactin levels among transgender women on estrogen therapy: A systematic review.
    Wilson LM; Baker KE; Sharma R; Dukhanin V; McArthur K; Robinson KA
    Int J Transgend Health; 2020; 21(4):391-402. PubMed ID: 34993517
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hormonal Therapy of Prostatic Cancer.
    Scott WW; Menon M; Walsh PC
    Cancer; 1980 Apr; 45 Suppl 7():1929-1936. PubMed ID: 29603164
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of combined hormone and radiotherapy on prostatic cancer. Light- and electron microscopy findings].
    Kastendieck H; Altenähr E
    Verh Dtsch Ges Pathol; 1975; 59():559. PubMed ID: 1217130
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effectiveness of continuously administered estrogen on the prostatic carcinoma (author's transl)].
    Takeuchi H; Yamauchi A
    Nihon Hinyokika Gakkai Zasshi; 1978 Dec; 69(12):1552-61. PubMed ID: 745324
    [No Abstract]   [Full Text] [Related]  

  • 53. [Treatment of prostatic carcinoma with hexoestrol dibromoacetate: report of 78 cases (author's transl)].
    Miao TJ
    Zhonghua Wai Ke Za Zhi; 1980 Dec; 18(6):502-3. PubMed ID: 6263560
    [No Abstract]   [Full Text] [Related]  

  • 54. [Hormonal therapy in prostatic carcinoma].
    Chitayat D; Golomb J; Braf Z
    Harefuah; 1985 Mar; 108(6):304-7. PubMed ID: 3916419
    [No Abstract]   [Full Text] [Related]  

  • 55. [Effect of the functional state of the liver on the course of prostatic cancer and the effectiveness of estrogen therapy].
    Pytel' AIa
    Urol Nefrol (Mosk); 1973; 38(5):47-9. PubMed ID: 4782767
    [No Abstract]   [Full Text] [Related]  

  • 56. [Hormone therapy in prostatic cancer: indications and counterindications].
    Germa-Lluch JR; Marcuello-Gaspar E
    Actas Urol Esp; 1978; 2(3):101-10. PubMed ID: 676827
    [No Abstract]   [Full Text] [Related]  

  • 57. Hormonal therapy of cancer.
    Kelley RM
    Mod Treat; 1966 Jul; 3(4):766-90. PubMed ID: 5941803
    [No Abstract]   [Full Text] [Related]  

  • 58. [Laboratory methods for the regulation of estrogen therapy in patients with prostatic carcinoma].
    Aslamazov JG; Sapiro SB; Hradec E; Jarolím L
    Cas Lek Cesk; 1983 Apr; 122(13):388-9. PubMed ID: 6861175
    [No Abstract]   [Full Text] [Related]  

  • 59. [Recurrent thrombosis of the subclavian vein during estrogen therapy of prostatic cancer].
    Carl P
    Dtsch Med Wochenschr; 1985 Jan; 110(4):155. PubMed ID: 3967599
    [No Abstract]   [Full Text] [Related]  

  • 60. [Preliminary results on the use of cyproterone (S H-714) acetate in advanced prostatic carcinoma].
    Nehme-Haily D; Osorio DG; Veenema RJ; Markewitz M
    Rev Venez Urol; 1968; 20(1):19-26. PubMed ID: 5740110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.